Comparison of effect of glycoprotein IIb/IIIa inhibitors during percutaneous coronary interventions on risk of hemorrhagic stroke in patients ≥75 years of age versus those <75 years of age

Ioannis Iakovou, George Dangas, Roxana Mehran, Gary S. Mintz, Alexandra J. Lansky, Eve D. Aymong, Eugenia Nikolsky, Tudor Vagaonescu, Lynne A. Glasser, Gregg W. Stone, Martin B. Leon, Jeffrey W. Moses

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

Of 1,369 consecutive patients who underwent stent-assisted coronary angioplasty and who were treated with glycoprotein IIb/IIIa inhibitors during these procedures, 17.5% were ≥75 years of age. Compared with patients <75 years old, those ≥75 years of age had similar procedural and in-hospital outcomes but significantly higher rates of hemorrhagic stroke (0.08% vs 1.2%, p <0.001).

Original languageEnglish
Pages (from-to)1083-1086
Number of pages4
JournalAmerican Journal of Cardiology
Volume92
Issue number9
DOIs
StatePublished - 1 Nov 2003
Externally publishedYes

Fingerprint

Dive into the research topics of 'Comparison of effect of glycoprotein IIb/IIIa inhibitors during percutaneous coronary interventions on risk of hemorrhagic stroke in patients ≥75 years of age versus those <75 years of age'. Together they form a unique fingerprint.

Cite this